Can the New Cervical Cancer Screening, Management Guidelines Be Simplified?

Sarah Feldman, M.D., M.P.H., of Harvard Medical School, Boston, writes: “Women in the United States are cared for in private offices, public health clinics, and other diverse settings, with different tests and resources for cervical cancer screening. Thus, obtaining more evidence about a variety of cost-effective approaches to screening and surveillance should be a priority.”

“Furthermore, as HPV testing becomes an option separate from cotesting, new screening and surveillance strategies should be studied in as many diverse settings as possible. Although the [American Society for Colposcopy and Cervical Pathology] guidelines for the management of abnormal cervical cancer screening tests are well intentioned, they should and can be simplified. Guidelines that are easy to implement in clinical practice help clinicians avoid mistakes and optimize patient care,” Feldman concludes.


Sarah Feldman MD, MPH. Can the New Cervical Cancer Screening and Management Guidelines Be Simplified? JAMA Intern Med. 2014; 174(7):-. doi:10.1001/jamainternmed.2014.576

Editor’s Note:

Dr. Feldman is paid to write chapters for UptoDate, a peer-reviewed online textbook. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory:

To contact author Sarah Feldman, M.D., call Lori J. Schroth at 617-525-6374 or email

saypeople gives you the news and information about Science, Research, Technology, Business and Islam.